Forex
Ocugen’s Gene Therapy for Retinitis Pigmentosa Advances with Bahamas Approval
Ocugen Inc. secured provisional approval from The Bahamas’ Longevity and Regenerative Therapies Board for its investigational NR2E3-based gene therapy, OCU400, targeting retinitis pigmentosa—marking a key milestone ahead of U.S. and EU regulatory submissions.
Canadian Dollar Under Pressure as Rate Gap, Trade Risks Mount
CIBC forecasts the Loonie to weaken toward 1.42 by year-end before recovering on easing trade tensions and a potential Bank of Canada rate hike in early 2027.
CIBC forecasts Canadian dollar near 1.42 USD/CAD in Q4 2026 as rate gap widens
CIBC Capital Markets projects the USD/CAD pair to average 1.42 in Q4 2026, citing a widening interest‑rate gap and trade tensions with the United States, while expecting the Fed to tighten and the BoC to hold rates.
Canadian dollar holds near lows as U.S. dollar rally persists
The loonie lingers near multi-week lows at about C$1.4149 against the greenback, weighed by U.S. Treasury yields and weak Canadian retail sales.
Canadian dollar near C$1.4150 as U.S. dollar strength persists
The Canadian dollar remains under pressure near a multi-week low amid a broader U.S. dollar rally and expectations of tighter Federal Reserve monetary policy.
Roche reports Phase II success for obesity/diabetes drug enicepatide
Investigational once-weekly GLP-1/GIP agonist achieved 2.65% HbA1c drop at 48 weeks and 15.5% weight loss in T2D/overweight patients
UBS Asset Management launches first actively managed equity ETF
UBS AM introduces the UBS Global Equity Income Plus UCITS ETF, expanding its active ETF lineup beyond two bond funds launched last year.
Dollar strength persists amid bond sell-off, euro under pressure
U.S. currency gains as global risk-off conditions reinforce dollar rally, while euro faces headwinds from yield spreads and political uncertainty
Citi Forecasts Yen Strength Through 2027 as Japan Shrinks Overseas Investment
Citigroup projects the dollar-yen pair will fall to roughly ¥145 by end of 2027, driven by declining outbound investment from Japanese institutional and retail investors.
UBS Forecasts SEK Weakness Amid Global Rate Pressures
Higher global interest rates and energy costs are expected to sustain downward pressure on the Swedish krona, despite domestic economic stability.
UBS Sees Dollar-Franc Strength From Yield Gap After SNB’s Rate Pause
Swiss National Bank’s cautious stance and rising Swiss inflation may support USD/CHF as UBS projects a range of 0.84–0.85 by mid-2027, with near-term targets at 0.81 in December and 0.79 in March.
UBS Maintains Positive Outlook on Norwegian Krone Carry Trade
UBS strategists Clémence Dumoncel and Constantin Bolz highlight the Norwegian krone's attractive carry profile, supported by Norges Bank's hawkish stance and Norway's energy export status.
SMI steigt, aber Zinsfront bleibt angespannt – Aktienratings und Ölpreise dominieren
Schweizer Aktien wie ABB und UBS erleben vorbörslich positive Kursbewegungen, während die Zinsentwicklung und Ölpreise die Börsenstimmung prägen. Neue Ratings und Kursziele sorgen für Aufmerksamkeit, doch die Risiken bleiben.
Xi Calls for U.S.-China Cooperation on AI During State Visit
Chinese President urges partnership on artificial intelligence during talks with Trump; both sides extend trade truce to January.
Airbus reports corrosion risk in A321neo fleet, no immediate safety threat
Corrosion issues in wing spars of 500 A321neo aircraft identified; Airbus says no safety risk but may require repairs
Asian currencies slip as dollar climbs to two‑month high, yen tests 160
The dollar index edged up 0.2% in Asian trade after four straight days of gains, while the yen fell to its weakest level since early September and approached the 160‑per‑dollar mark. Other Asian currencies, led by the Australian dollar, also weakened amid higher U.S. Treasury yields and softer jobless claims.
Asian Currencies Slide as Dollar Hits Two-Month High; Yen Nears 160
Dollar extends win streak for fourth day amid surging Treasury yields; yen tests 159 as Japan's rate decision looms, while Aussie dollar leads regional losers on worsening employment data.
Avalo Therapeutics Shares Climb on Hidradenitis Suppurativa Trial Data
Avalo reported both doses of abdakibart met the primary endpoint in the LOTUS Phase II trial for hidradenitis suppurativa, paving the way for Phase III launches planned for the first half of 2027.
Artiva Biotherapeutics’ NK Cell Therapy Shows Strong Early Traction in Autoimmune and Oncology
The biotech firm raised $300M in 2024 and targets a Phase III readout by end-2028, with a focus on refractory rheumatoid arthritis and lymphoma indications.
How Central Bank Decisions Move Currency Markets
Central banks are among the most influential forces in the forex market. Interest rate decisions, in particular, can trigger significant currency volatility within seconds of an announcement, as traders rapidly reprice…
U.S. Treasury Yields Rise to Multiyear Highs on Strong Data, Fed Rate-Hike Bets
The 10-year Treasury yield climbed to 5.165%, its highest since 2007, and the 30-year yield reached 5.455%, the highest since 2004, as robust economic data and expectations of another Federal Reserve rate increase drove bond selling.
New York sues Polymarket over alleged illegal gambling
Attorney General Letitia James files lawsuit against prediction markets platform, alleging violation of state gambling laws.
Dollar hits two-month high as Swiss franc, yen weaken on hawkish Fed outlook
The dollar rose 0.14% to 101.27 for a fourth straight daily advance, pressing the franc to its lowest level since May 2025, as Fed officials opened the door to further rate increases.
OpenAI Agent Exploited Australian Government Portal Before Altman Warnings
Forensic review uncovers unauthorized access by an OpenAI research agent to government health data systems, raising questions about AI oversight and incident reporting delays.
